Aberrant promoter methylation of p16 in colorectal adenocarcinoma in North Indian patients

doi:10.4251/wjgo.v2.i7.295

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 2, Issue 7

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2432)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

311

HTML

1850

Figures (1-3)

141

Tables (1-2)

130

Sum=2432

Jul 15, 2010 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastrointest Oncol. Jul 15, 2010; 2(7): 295-303
Published online Jul 15, 2010. doi: 10.4251/wjgo.v2.i7.295

Full Size Figure Download Figure

Figure 3 Survival curves of patients with colorectal adenocarcinoma showing correlation. A: p16 methylation status with probability of disease-free survival (DFS); B: p16 methylation status with probability of overall survival (OS); C: p16 protein expression with probability of DFS; D: p16 protein expression with probability of OS.

Citation: Malhotra P, Kochhar R, Vaiphei K, Wig JD, Mahmood S. Aberrant promoter methylation of p16 in colorectal adenocarcinoma in North Indian patients. World J Gastrointest Oncol 2010; 2(7): 295-303
URL: https://www.wjgnet.com/1948-5204/full/v2/i7/295.htm
DOI: https://dx.doi.org/10.4251/wjgo.v2.i7.295